GER:BRM

Bristol-myers Squibb Company Stock Signals

etoro logo Buy BRM
*Your capital is at risk
40.79€
-0.165 (-0.403%)
At Close: Nov 18, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -0.043 2 days ( 0.403 % )
Last Price 40.79€ -0.403 %
High/ Low 40.31€ - 40.79€ 0.335%
Chg 7 Days -1.82 % $41.54 40.79€
Chg 30 Days 9.74 % $37.17 40.79€
Chg 12 mos -23.97 % $53.64 40.79€
Trend - 3 mos -2.18 % Width: 16.79 %
Trend - 12 mos -34.42 % Width: 24.04 %
Pred. range - 3 mos 35.75€ - 41.75€ -12.34 % - 2.38 %
Pred. range - 12 mos 22.45€ - 27.85€ -44.96 % - -31.72 %
Short MA avg 3 mos Sell Nov 13, 2025 - 4 days
Long MA avg 3 mos Buy Oct 29, 2025 - 15 days
Short/Long MA avg 3 mos Buy Nov 03, 2025 - 12 days
Short MA avg 12 mos Buy Oct 29, 2025 - 15 days
Long MA avg 12 mos Buy Oct 30, 2025 - 14 days
Short/Long MA avg 12 mos Sell Apr 04, 2025 - 160 days
Pivot Short Buy Nov 13, 2025 - 4 days
Bollinger Buy Nov 13, 2025 - 4 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT BRISTOL-MYERS SQUIBB COMPANY
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE